Akebia Therapeutics Inc.
AKBA | NASDAQ
$0.94
+$0.02 (+2.65%)
At close: Sep 21, 2026, 4:00 PM ET
$0.95
+$0.01 (+0.95%)
Pre-market:
Sep 22, 2026, 4:36 AM ET
Employees
194
Change (1Y)
13
Growth (1Y)
+7.18%
Revenue / Employee
$1,129,165
Profits / Employee
-$152,918
Market Cap
$251.76M
Employees History
| Date | Employees | Change | % Change |
|---|---|---|---|
| Dec 31, 2025 | 194 | 13 | +7.18% |
| Dec 31, 2024 | 181 | 14 | +8.38% |
| Dec 31, 2023 | 167 | -38 | -18.54% |
| Dec 31, 2022 | 205 | -221 | -51.88% |
| Dec 31, 2021 | 426 | 47 | +12.40% |
| Dec 31, 2020 | 379 | 19 | +5.28% |
| Dec 31, 2019 | 360 | 35 | +10.77% |
| Dec 31, 2018 | 325 | 211 | +185.09% |
| Dec 31, 2017 | 114 | 24 | +26.67% |
| Dec 31, 2016 | 90 | 27 | +42.86% |
| Dec 31, 2015 | 63 | 20 | +46.51% |
| Dec 31, 2014 | 43 | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AKBA